For citations:
Parfenov VA, Bogdanov EI, Laskov VB, Makarov NS, Pisova NV, Salina EA, Chefranova ZY, Chichanovskaya LV. Multicenter, randomized, double-blind study of the efficacy and safety of prolonged release tolperisone hydrochloride 450 mg (Mydocalm® Long, once daily) and tolperisone hydrochloride 150 mg (three times daily) for acute non-specific lower back pain. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021;13(6):14-22. (In Russ.)
Email this article 